SGA
Sector Gamma AS Portfolio holdings
AUM
$306M
This Quarter Return
+10.95%
1 Year Return
+4.68%
3 Year Return
+19.67%
5 Year Return
+46.47%
10 Year Return
+161.43%
AUM
$629M
AUM Growth
+$629M
(+18%)
Cap. Flow
+$52.3M
Cap. Flow
% of AUM
8.32%
Top 10 Holdings %
Top 10 Hldgs %
65.36%
Holding
29
New
3
Increased
9
Reduced
8
Closed
3
Top Buys
| 1 |
Bristol-Myers Squibb
BMY
|
$18.1M |
| 2 |
Perrigo
PRGO
|
$16.4M |
| 3 |
Abbott
ABT
|
$15.2M |
| 4 |
Labcorp
LH
|
$12M |
| 5 |
Elevance Health
ELV
|
$10.6M |
Top Sells
| 1 |
Merck
MRK
|
$16.7M |
| 2 |
Exelixis
EXEL
|
$7.76M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
$7.32M |
| 4 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$5.93M |
| 5 |
United Therapeutics
UTHR
|
$5.28M |
Sector Composition
| 1 | Healthcare | 98.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Abbott
ABT
$231B
| $58.6M | 9.31% | 1,318,642 +342,052 | +35% | +$15.2M |
|
2
Eli Lilly
LLY
$657B
| $55.6M | 8.85% | 661,350 -5,700 | -0.9% | -$479K |
|
3
Baxter International
BAX
$12.7B
| $53.7M | 8.55% | 1,036,233 +83,400 | +9% | +$4.33M |
|
|
4
Bristol-Myers Squibb
BMY
$96B
| $42.5M | 6.77% | 782,390 +333,100 | +74% | +$18.1M |
|
5
Revvity
RVTY
$10.5B
| $36.2M | 5.76% | 623,408 | – | – |
|
6
Boston Scientific
BSX
$156B
| $35.4M | 5.63% | 1,423,880 +168,300 | +13% | +$4.19M |
|
|
7
Elevance Health
ELV
$71.8B
| $33.8M | 5.38% | 204,610 +63,800 | +45% | +$10.6M |
|
8
Ironwood Pharmaceuticals
IRWD
$214M
| $33.1M | 5.27% | 1,940,778 -31,900 | -2% | -$544K |
|
|
SHPG
9
DELISTED
Shire pic
SHPG
| $31.5M | 5.01% | 180,761 +33,800 | +23% | +$5.89M |
|
10
Gilead Sciences
GILD
$140B
| $30.5M | 4.84% | 448,490 +89,200 | +25% | +$6.06M |
|
|
11
Vertex Pharmaceuticals
VRTX
$100B
| $29.2M | 4.64% | 267,050 -66,900 | -20% | -$7.32M |
|
12
Masimo
MASI
$7.59B
| $24.1M | 3.83% | 258,218 -54,786 | -18% | -$5.11M |
|
13
Bio-Rad Laboratories Class A
BIO
$8.06B
| $22.7M | 3.62% | 114,042 | – | – |
|
14
Integra LifeSciences
IART
$1.18B
| $20.6M | 3.27% | 488,230 +207,023 | +74% | +$8.72M |
|
|
PDCO
15
DELISTED
Patterson Companies, Inc.
PDCO
| $17.5M | 2.78% | 386,232 | – | – |
|
16
McKesson
MCK
$85.4B
| $17.1M | 2.72% | 115,200 | – | – |
|
|
17
Perrigo
PRGO
$3.27B
| $16.4M | 2.61% | +247,340 | New | +$16.4M |
|
18
Cigna
CI
$80.3B
| $12.3M | 1.96% | 84,270 -11,000 | -12% | -$1.61M |
|
|
19
Labcorp
LH
$23.1B
| $12M | 1.91% | +83,900 | New | +$12M |
|
|
LPNT
20
DELISTED
LifePoint Health, Inc.
LPNT
| $10.8M | 1.72% | 164,714 | – | – |
|
|
MNTA
21
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $10.1M | 1.61% | 756,765 -98,500 | -12% | -$1.31M |
|
|
IPXL
22
DELISTED
Impax Laboratories, Inc.
IPXL
| $6.76M | 1.08% | 534,311 +35,158 | +7% | +$445K |
|
23
Owens & Minor
OMI
$378M
| $5.05M | 0.8% | 145,874 -68,298 | -32% | -$2.36M |
|
24
Lexicon Pharmaceuticals
LXRX
$400M
| $4.77M | 0.76% | +332,300 | New | +$4.77M |
|
25
Tenet Healthcare
THC
$16.3B
| $4.46M | 0.71% | 252,080 | – | – |
|